日本語 >>
TOP page
Journal
Presentation
（Last updated : 2026-08-10 15:44:02）
Hiroyuki Kamao
Department
Kawasaki Medical School Kawasaki Medical School, Department of Ophthalmology 1,
Position
Associate Professor
■
Journal
1.
2026/07/30
Noninfectious intraocular inflammation with hypopyon after intravitreal aflibercept 8 mg injection for neovascular age-related macular degeneration: a case report
2.
2026/07/28
Association of Vortex Vein Morphology with Punctate Hyperfluorescence on ICGA in Neovascular Age-Related Macular Degeneration
3.
2026/04/09
Five-Year Changes in Pachydrusen with Late-Phase Hyperfluorescence on Indocyanine Green Angiography.
4.
2025/12/04
Clinical Characteristics of Patients with Neovascular Age-Related Macular Degeneration and Responses to Anti-VEGF Therapy: Four-Group Stratification Based on Drusen and Punctate Hyperfluorescence
5.
2025/09/20
Impact of Punctate Hyperfluorescence Status on Treatment Outcomes of Faricimab Versus Aflibercept in Neovascular Age-Related Macular Degeneration
6.
2025/07/19
Punctate Hyperfluorescence as a Favorable Predictive Factor for Treatment Response Following a Switch to Brolucizumab for Patients with Aflibercept-Refractory Neovascular Age-Related Macular Degeneration
7.
2025/02/21
Treatment Outcomes of Simple and Complex Central Serous Chorioretinopathy.
8.
2024/09/30
Graft survival of major histocompatibility complex deficient stem cell-derived retinal cells
9.
2024/09/12
Clinical Characteristics of Punctate Hyperfluorescence Spots in the Fellow Eye of Patients with Unilateral Macular Neovascularization with No Drusen.
10.
2024/06/27
Clinical characteristics of unilateral macular neovascularization patients with pachydrusen in the fellow eye.
11.
2024/01/30
The Effect of a Loading Dose Regimen in the Switch to Brolucizumab for Patients with Aflibercept-Resistant nAMD
12.
2021/04/27
Clinical characteristics of neovascular age-related macular degeneration without typical drusen
13.
2021/03/22
A ROCK inhibitor promotes graft survival during transplantation of iPS-cell-derived retinal cells
14.
2021/01
Immunological aspects of RPE cell transplantation
15.
2020
A strategy for personalized treatment of iPS-retinal immune rejections assessed in cynomolgus monkey models.
16.
2019/06
ROCK inhibitor-induced promotion of retinal pigment epithelial cell motility during wound healing
17.
2019/04
Mycoplasma ocular infection in subretinal graft transplantation of iPS cells-derived retinal pigment epithelial cells
18.
2019/03
Evaluation of retinal pigment epithelial cell cytotoxicity of recombinant tissue plasminogen activator using human-induced pluripotent stem cells
19.
2018/11
Effects of smoking on outcomes of antivascular endothelial growth factor therapy in patients with neovascular age-related macular degeneration smoking and anti-VEGF therapy in nAMD.
20.
2017/03
Autologous induced stem-cell-derived retina cells for macular degeneration
21.
2017/01
Evaluation of the surgical device and procedure for extracellular matrix-scaffold-supported human iPSC-derived retinal pigment epithelium cell sheet transplantation.
22.
2017
Detection of retinal pigment epithelium-specific antibody in iPSC-derived retinal pigment epithelium transplantation models
23.
2016/10
Successful transplantation of retinal pigment epithelial cells from MHC homozygote iPSCs in MHC-matched models
24.
2015/05
Protective effects of human iPS-derived retinal pigmented epithelial cells in comparison with human mesenchymal stromal cells and human neural stem cells on the degenerating retina in rd1 mice
25.
2015/01
Inhibition of T-cell activation by retinal pigment epithelial cells derived from induced pluripotent stem cells.
26.
2015
Intravitreal recombinant tissue plasminogen activator without gas injection in a patient with massive submacular hemorrhage associated with age-related macular degeneration: A case report
27.
2014/11
Objective evaluation of the degree of pigmentation in human induced pluripotent stem cell-derived RPE.
28.
2014/02
Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application
29.
2014/01
Tumorigenicity studies of induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) for the treatment of age-related macular degeneration
30.
2013/12
Generation of retinal pigment epithelium from human induced pluripotent stem cells showed polarized secretion of VEGF and PEDF
31.
2013/08
Pigment epithelium-derived factor secreted from retinal pigment epithelium facilitates apoptotic cell death of iPSC
32.
2013/01
A point mutation in Semaphorin 4A associates with defective endosomal sorting and causes retinal degeneration
33.
2013
induced pluripotent stem cells derived retinal pigment epithlium cell-sheets for clinical transplantation
Display 5 items
Display all(33)
■
Presentation
1.
2023/10/06
Selective Degeneration of Retinal Photoreceptor Cell in Prosaposin Transgenic Mice （Speech，General）
2.
2023/07/06
Degeneration of Retinal Photoreceptor Cell in Prosaposin Transgenic Mice （Poster notice，General）
3.
2018/05/02
Rock inhibitor-induced enhancement of retinal pigment epithelial cell adhesion. （Poster notice，General）
4.
2014/05/08
Protective effects of human iPS-derived retinal pigmented epithelial cells in comparison with human mesenchymal stromal cells and human neural stem cells on the degenerating retina in rd1 mice （Poster notice，General）
5.
2014/05/05
Evaluation of Degree of Pigmentation as an Indicator of Maturation status in Human iPSC-RPE （Poster notice，General）
6.
2014/04/02
Comparison of imaging in gas-filled eyes using swept-source optical coherence tomography and spectral-domain optical coherence tomography （Poster notice，General）
7.
2014/04/02
Development of a novel device and surgery for human iPSC-RPE Cell-Sheet transplantation （Poster notice，General）
8.
2013/05/10
Development of a novel device and surgery for subretinal transplantation of human iPSC-RPE cell-sheet （Poster notice，General）
9.
2012/06/12
induced Pluliptent Stem Cells-Derived Retinal Pigemnet Epithelial Cell Sheets For Clinical Therapy （Speech，General）
10.
2012/05/10
Gene Expression and Immunogenicity of induced Pluliptent Stem Cells-Derived Retinal Pigemnet Epithelial Cells （Poster notice，General）
11.
2012/05/06
A prototype Instrument for subretinal transplantation of induced pluripotent stem (iPS) cell-derived retinal pigment epithelial cell sheets. （Poster notice，General）
12.
2012/02/28
Characterization of iPSC-derived retinal pigment epithelial cell sheets for clinical therapy （Speech，General）
13.
2012/02/16
Gene Expression and Immunogenicity of induced Pluliptent Stem Cells-Derived Retinal Pigemnet Epithelial Cells （Poster notice，General）
14.
2011/12/03
A prototype instrument for subretinal transplantation of retinal pigment epithelial cell sheets.
15.
2011/09/13
Immunogenicity of induced pluripotent stem cells-derived retinal pigment epithelial cells （Speech，General）
16.
2011/05/04
Manipulation of cell sheets with the pneumatic balloon actuator. （General）
17.
2011/05/04
Preparation of iPS-derived RPE sheets for transplantation therapy （Poster notice，General）
18.
2010/05/03
Induction of RPE Cells From Monkey iPS Cells （Poster notice，General）
Display 5 items
Display all(18)
